TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34068437

Group type: EXPERIMENTAL
Intervention: FV intervention arm (2 h workshop on increasing FV consumption and related food literacy)
Number of subjects: 803

Group type: COMPARATOR
Intervention: More appreciation control arm (2 h workshop on increasing appreciation of children)
Number of subjects: 803

Group type: COMPARATOR
Intervention: Less criticism control arm (2 h workshop on reducing criticism of children)
Number of subjects: 803

Group type: EXPERIMENTAL
Intervention: Both arms (FV and MALC)
Number of subjects: 803
Study: 33603241

Group type: EXPERIMENTAL
Intervention: Nivolumab + Ipilimumab
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Nivolumab
Number of subjects: 44
Study: 35503746

Group type: EXPERIMENTAL
Intervention: Locator overdenture (LOD)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Ball overdenture (BOD)
Number of subjects: 18
Study: 36413710

Group type: EXPERIMENTAL
Intervention: Daratumumab plus bortezomib and dexamethasone (D-Vd)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bortezomib and dexamethasone (Vd)
Number of subjects: 0
Study: 33592132

Group type: EXPERIMENTAL
Intervention: Processed meat intake (salami)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Habitual intake of sausages
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Total processed meat intake
Number of subjects: 12
Study: 32795162

Group type: EXPERIMENTAL
Intervention: Trunk extensor stimulation during sudden stops events
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Algorithm to detect wheelchair sudden stops
Number of subjects: 6
Study: 33484344

Group type: EXPERIMENTAL
Intervention: Pie-crusting technique of the femoral origin of medial collateral ligament (MCL)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Conventional medial release (classic sub-periosteal release of the tibial insertion of superficial MCL)
Number of subjects: 80
Study: 35610157

Group type: EXPERIMENTAL
Intervention: Project Dads in Nutrition Education
Number of subjects: 480
Study: 32066032

Group type: EXPERIMENTAL
Intervention: Low-dose CT (66.7% tube load)
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Ultralow-dose CT (33.3% tube load)
Number of subjects: 139

Group type: COMPARATOR
Intervention: Standard-dose CT (100% tube load)
Number of subjects: 139
Study: 34271984

Group type: EXPERIMENTAL
Intervention: Internet-based Emotion Regulation Individual Therapy for Adolescents (ERITA) as an add-on to treatment as usual
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 0
Study: 32417925

Group type: EXPERIMENTAL
Intervention: Erector Spinae Plane Block (ESPB)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Serratus Anterior Plane Block (SAPB)
Number of subjects: 60
Study: 35303255

Group type: EXPERIMENTAL
Intervention: Aerobic training
Number of subjects: 36

Group type: COMPARATOR
Intervention: Balance training
Number of subjects: 36
Study: 34341035

Group type: EXPERIMENTAL
Intervention: His-Purkinje system pacing (HPSP)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Cardiac resynchronisation therapy (CRT)
Number of subjects: 46
Study: 33196739

Group type: EXPERIMENTAL
Intervention: 2,940 nm fractional erbium:YAG laser treatment
Number of subjects: 18
Study: 34031053

Group type: EXPERIMENTAL
Intervention: SUBA-itraconazole (S-ITZ)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional itraconazole (C-ITZ)
Number of subjects: 0
Study: 32151965

Group type: EXPERIMENTAL
Intervention: SMART (Self‐management for people with epilepsy and a history of negative health events)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: SMART
Number of subjects: 120

Group type: COMPARATOR
Intervention: Wait-list
Number of subjects: 120
Study: 34787930

Group type: EXPERIMENTAL
Intervention: End-of-life (EOL) conversation with oncologist
Number of subjects: 672

Group type: EXPERIMENTAL
Intervention: Completion of an advance directive (AD)
Number of subjects: 672

Group type: COMPARATOR
Intervention: No EOL conversation
Number of subjects: 672

Group type: COMPARATOR
Intervention: No advance directive (AD)
Number of subjects: 672
Study: 33530238

Group type: EXPERIMENTAL
Intervention: Short one-on-one nursing intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 32182226

Group type: EXPERIMENTAL
Intervention: Respiratory resistance exercise group (n=22)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group (n=22)
Number of subjects: 44
Study: 36416319

Group type: EXPERIMENTAL
Intervention: Biorepair toothpaste (HA-based desensitizing toothpaste)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Dontodent toothpaste (HA-based desensitizing toothpaste)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: HA paste
Number of subjects: 4

Group type: COMPARATOR
Intervention: Control (no desensitizing treatment)
Number of subjects: 4
Study: 33533989

Group type: EXPERIMENTAL
Intervention: NI-RADS criteria for primary site
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: NI-RADS criteria for neck
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: DWI of primary site
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: NI-RADS categories of primary site
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: NI-RADS categories of neck
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: NI-RADS categories 2a, 2b, and 3 of primary site
Number of subjects: 104
Study: 32212765

Group type: EXPERIMENTAL
Intervention: Spatial-language and play condition (n = 26)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Play-only condition (n = 24)
Number of subjects: 50
Study: 33484370

Group type: EXPERIMENTAL
Intervention: MYmind mindfulness program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 0
Study: 34939119

Group type: EXPERIMENTAL
Intervention: We Can Quit (group support + nicotine replacement therapy)
Number of subjects: 194

Group type: COMPARATOR
Intervention: Individual support delivered by health professionals (Control)
Number of subjects: 194
Study: 34145727

Group type: EXPERIMENTAL
Intervention: Duloxetine 30 mg orally (group D)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Starch placebo capsules (group C)
Number of subjects: 70
Study: 34883818

Group type: EXPERIMENTAL
Intervention: Floating heel running shoes
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional footwear
Number of subjects: 20
Study: 35512259

Group type: EXPERIMENTAL
Intervention: 3-month treatment group (FOLFOX or CAPOX)
Number of subjects: 1291

Group type: COMPARATOR
Intervention: 6-month treatment group (FOLFOX or CAPOX)
Number of subjects: 1291

Group type: EXPERIMENTAL
Intervention: mFOLFOX6
Number of subjects: 1291

Group type: EXPERIMENTAL
Intervention: CAPOX
Number of subjects: 1291
Study: 34670277

Group type: EXPERIMENTAL
Intervention: 5-aminolevulinic acid (5-ALA) with BLUE400 filter system
Number of subjects: 162
Study: 35778578

Group type: EXPERIMENTAL
Intervention: Viabahn® and Excluder® iliac extension (V-E)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Two Viabahn® parallel stents (V-V)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Post dilatation with non-compliant balloon for internal iliac and compliant balloon for external iliac
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Post dilatation with two non-compliant balloons
Number of subjects: 0
Study: 33540715

Group type: EXPERIMENTAL
Intervention: Educational intervention involving posters and a web app
Number of subjects: 316

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 316
Study: 33660345

Group type: EXPERIMENTAL
Intervention: Hyperoxic reperfusion (HR) in SHR and ZR
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Hyperoxic reperfusion (HR) in SHR
Number of subjects: 106

Group type: COMPARATOR
Intervention: Normoxic reperfusion (NR) in SHR and ZR
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Hyperoxic reperfusion (HR) in Wistar rats (WR)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Normoxic reperfusion (NR) in Wistar rats (WR)
Number of subjects: 106
Study: 34273635

Group type: EXPERIMENTAL
Intervention: IFNβ1a + hydroxychloroquine + lopinavir/ritonavir + umifenovir
Number of subjects: 101

Group type: COMPARATOR
Intervention: IFNβ1a + hydroxychloroquine + lopinavir/ritonavir
Number of subjects: 101
Study: 36258848

Group type: EXPERIMENTAL
Intervention: Pregabalin 300 mg before anesthesia
Number of subjects: 105

Group type: COMPARATOR
Intervention: Placebo capsules before anesthesia and intravenous Mg sulfate 30 mg/kg during the perioperative period
Number of subjects: 105

Group type: COMPARATOR
Intervention: Placebo capsules before anesthesia and normal intravenous saline during the operation
Number of subjects: 105
Study: 34610178

Group type: EXPERIMENTAL
Intervention: Viburnum opulus 1000 mg peroral 3 × 2 and diclofenac 50 mg peroral on-demand
Number of subjects: 86

Group type: COMPARATOR
Intervention: Tamsulosin 0.4 mg peroral 1 × 1 and diclofenac 50 mg peroral on-demand
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Viburnum opulus in 5-10 mm stone size subgroup
Number of subjects: 86

Group type: COMPARATOR
Intervention: Tamsulosin in 5-10 mm stone size subgroup
Number of subjects: 86
Study: 32151735

Group type: EXPERIMENTAL
Intervention: Functional Training (FT)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Traditional Training (TT)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 43
Study: 35938329

Group type: EXPERIMENTAL
Intervention: 4-cm moxa stick
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: 3-cm moxa stick
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: 2-cm moxa stick
Number of subjects: 240

Group type: COMPARATOR
Intervention: Acupuncture
Number of subjects: 240
Study: 34784991

Group type: EXPERIMENTAL
Intervention: Group therapy intervention (Recovery through Group Study - ReGroup)
Number of subjects: 203
Study: 34548367

Group type: EXPERIMENTAL
Intervention: Weekly injections of 250 mg 17-hydroxyprogesterone caproate
Number of subjects: 1355

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1355
Study: 35621073

Group type: EXPERIMENTAL
Intervention: Nano-curcumin (160 mg) administered via nasogastric tube twice a day for 10 days
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo administered via nasogastric tube twice a day for 10 days
Number of subjects: 40
Study: 32239161

Group type: EXPERIMENTAL
Intervention: Worsening sleep disturbance
Number of subjects: 599

Group type: EXPERIMENTAL
Intervention: Persistent sleep disturbance
Number of subjects: 599

Group type: COMPARATOR
Intervention: Improving sleep
Number of subjects: 599
Study: 35482076

Group type: EXPERIMENTAL
Intervention: Anlotinib
Number of subjects: 78

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78
Study: 34224267

Group type: EXPERIMENTAL
Intervention: Restrictive blood transfusion strategy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Liberal blood transfusion strategy
Number of subjects: 0
Study: 36129698

Group type: EXPERIMENTAL
Intervention: Ready2Change telephone-delivered intervention (4 to 6 sessions with a psychologist)
Number of subjects: 344

Group type: COMPARATOR
Intervention: Active control (four 5-minute telephone check-ins and pamphlets)
Number of subjects: 344
Study: 32320797

Group type: COMPARATOR
Intervention: Tiotropium Respimat 5 μg once daily added to high-dose ICS plus long-acting β2-agonist (severe asthma)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tiotropium Respimat 2.5 or 5 μg once daily added to medium-dose ICS (moderate asthma)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tiotropium Respimat (both dosages)
Number of subjects: 0
Study: 35760720

Group type: EXPERIMENTAL
Intervention: Evolocumab (140 mg every 2 weeks)
Number of subjects: 372

Group type: EXPERIMENTAL
Intervention: Evolocumab (420 mg monthly)
Number of subjects: 372

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 372
Study: 32929910

Group type: EXPERIMENTAL
Intervention: Tranexamic acid sequential rivaroxaban
Number of subjects: 69

Group type: COMPARATOR
Intervention: Simple rivaroxaban (Control)
Number of subjects: 69
Study: 35869634

Group type: EXPERIMENTAL
Intervention: Eplontersen
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Eplontersen (injection into abdomen)
Number of subjects: 0
Study: 33140841

Group type: EXPERIMENTAL
Intervention: Outpatient (OP) setting
Number of subjects: 113

Group type: COMPARATOR
Intervention: Inpatient (IP) setting
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Both groups during IOL
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Postpartum experience questionnaire
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Future choice of catheter IOL
Number of subjects: 113
Study: 35152311

Group type: EXPERIMENTAL
Intervention: Cemented standard femoral stem (group 1)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Long femoral stem (group 2)
Number of subjects: 24
Study: 34292336

Group type: EXPERIMENTAL
Intervention: Abiraterone acetate with prednisone plus bone resorption inhibitors (BRIs)
Number of subjects: 745

Group type: COMPARATOR
Intervention: Abiraterone acetate with prednisone alone
Number of subjects: 745

Group type: EXPERIMENTAL
Intervention: Abiraterone acetate with prednisone plus BRIs
Number of subjects: 745

Group type: EXPERIMENTAL
Intervention: Abiraterone acetate with prednisone plus BRIs (low-volume disease subgroup)
Number of subjects: 745
Study: 32931996

Group type: EXPERIMENTAL
Intervention: Modified Mindfulness-Based Stress Reduction (MBSR)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Modified Mindfulness-Based Cognitive Therapy (MBCT)
Number of subjects: 57
Study: 616490283

Group type: EXPERIMENTAL
Intervention: 90‐minute nap opportunity
Number of subjects: 95

Group type: COMPARATOR
Intervention: Quiet wakefulness
Number of subjects: 95
Study: 35880279

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment (30 min, 3 times per week for 12 weeks) at acupoints including Baihui (GV20), Zhongwan (CV12), Shenting (GV24), Shenshu (BL23), Ciliao (BL32)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (healthy volunteers)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment
Number of subjects: 12
Study: 32597548

Group type: EXPERIMENTAL
Intervention: Intensified treatment (IT)
Number of subjects: 164

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Statin use
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Decrease in serum low-density lipoprotein cholesterol level
Number of subjects: 164
Study: 32809099

Group type: EXPERIMENTAL
Intervention: Longitudinal mixed models (LMM)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Longitudinal partial credit model (LPCM)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Time-to-event models for time to deterioration (TTD/TUDD)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Single-item scales using LPCM
Number of subjects: 7
Study: 32962406

Group type: EXPERIMENTAL
Intervention: PACAP38 (10 pmol/kg/min)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Vasoactive intestinal peptide (8 pmol/kg/min)
Number of subjects: 44
Study: 34369914

Group type: EXPERIMENTAL
Intervention: mHealth
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: mHealth+ (with virtual visits)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Enhanced usual care
Number of subjects: 74
Study: 36361390

Group type: EXPERIMENTAL
Intervention: Vibration group (VG) - 20 minutes of vibration (frequency: 30 Hz, amplitude: 5 mm) and 40 minutes of conventional exercise
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control group (CG) - 60 minutes of conventional exercise only
Number of subjects: 31
Study: 33115545

Group type: EXPERIMENTAL
Intervention: ItFits-toolkit
Number of subjects: 12

Group type: COMPARATOR
Intervention: Implementation-as-usual activities
Number of subjects: 12
Study: 35751945

Group type: EXPERIMENTAL
Intervention: Enhanced intervention with external facilitation for local change team activities
Number of subjects: 14012

Group type: COMPARATOR
Intervention: Core intervention with encouragement to form interagency workgroups
Number of subjects: 14012
Study: 33999548

Group type: EXPERIMENTAL
Intervention: 81 mg of aspirin per day
Number of subjects: 15076

Group type: EXPERIMENTAL
Intervention: 325 mg of aspirin per day
Number of subjects: 15076
Study: 33077258

Group type: EXPERIMENTAL
Intervention: Oral nintedanib (BIBF 1120) with oral cyclophosphamide (100 mg o.d.)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Placebo with oral cyclophosphamide (100 mg o.d.)
Number of subjects: 117
Study: 36410210

Group type: EXPERIMENTAL
Intervention: Lorlatinib
Number of subjects: 288

Group type: COMPARATOR
Intervention: Crizotinib
Number of subjects: 288
Study: 35273175

Group type: EXPERIMENTAL
Intervention: Lung recruitment maneuver (LRM) in the semi-lateral position
Number of subjects: 79

Group type: COMPARATOR
Intervention: Lung recruitment maneuver (LRM) in the supine position
Number of subjects: 79
Study: 33939335

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy
Number of subjects: 165

Group type: COMPARATOR
Intervention: Curative resection
Number of subjects: 165
Study: 32513495

Group type: EXPERIMENTAL
Intervention: Abaloparatide
Number of subjects: 296

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 296

Group type: COMPARATOR
Intervention: Teriparatide
Number of subjects: 296
Study: 35794067

Group type: EXPERIMENTAL
Intervention: OPC-61815 (16-mg injection)
Number of subjects: 294

Group type: COMPARATOR
Intervention: Oral tolvaptan (15-mg tablet)
Number of subjects: 294
Study: 33548206

Group type: EXPERIMENTAL
Intervention: Platelet-Rich Plasma (PRP) injection (3.5mL)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Normal saline injection (3.5mL)
Number of subjects: 26
Study: 32495521

Group type: EXPERIMENTAL
Intervention: Experiment group (n = 62) received 600 mg/d of calcium carbonate, 0.5 μg/d of alfacalcidol, and 70 mg/week of alendronate for 18 months
Number of subjects: 123

Group type: COMPARATOR
Intervention: Control group (n = 61) received 600 mg/d of calcium carbonate and 0.5 μg/d of alfacalcidol for 18 months
Number of subjects: 123
Study: 34592854

Group type: EXPERIMENTAL
Intervention: Nomogram for predicting survival rates
Number of subjects: 9739

Group type: EXPERIMENTAL
Intervention: Nomogram for predicting 3-year survival rate
Number of subjects: 9739

Group type: EXPERIMENTAL
Intervention: Nomogram for predicting 5-year survival rate
Number of subjects: 9739
Study: 35360212

Group type: EXPERIMENTAL
Intervention: Aerobic dance group (3 times per week for 3 months)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 68
Study: 32030555

Group type: EXPERIMENTAL
Intervention: CO2 laser (0.58 W) + TiF4
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: CO2 laser (0.58 W) + AmF/NaF/SnCl2
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: CO2 laser (0.69 W) + TiF4
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: CO2 laser (0.69 W) + AmF/NaF/SnCl2
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: AmF/NaF/SnCl2
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: TiF4
Number of subjects: 90

Group type: COMPARATOR
Intervention: Negative control (deionized water)
Number of subjects: 90
Study: 33715258

Group type: EXPERIMENTAL
Intervention: 1.2% simvastatin (SIM) gel covered with polypropylene membranes (PPPM)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo gel covered with polypropylene membranes (PPPM)
Number of subjects: 26
Study: 32565464

Group type: EXPERIMENTAL
Intervention: Standardised patient actor (SP) training intervention consisting of lectures, role-playing with SPs and group debriefing.
Number of subjects: 24

Group type: COMPARATOR
Intervention: Standard of care (control group).
Number of subjects: 24
Study: 32571889

Group type: EXPERIMENTAL
Intervention: Dual thromboprophylaxis (mechanical thromboprophylaxis with sequential compression devices and 28-day prophylaxis with low molecular weight heparin)
Number of subjects: 534

Group type: COMPARATOR
Intervention: Pre-intervention (low molecular weight heparin during admission and extended 28-day prophylaxis at surgeon's discretion)
Number of subjects: 534
Study: 33407547

Group type: EXPERIMENTAL
Intervention: Pediatric Tuina plus usual care
Number of subjects: 86

Group type: COMPARATOR
Intervention: Sham Tuina plus usual care
Number of subjects: 86
Study: 32723696

Group type: EXPERIMENTAL
Intervention: Personalized embryo transfer (PET) guided by endometrial receptivity analysis (ERA)
Number of subjects: 458

Group type: COMPARATOR
Intervention: Frozen embryo transfer (FET)
Number of subjects: 458

Group type: COMPARATOR
Intervention: Fresh embryo transfer
Number of subjects: 458

Group type: EXPERIMENTAL
Intervention: Personalized embryo transfer (PET)
Number of subjects: 458
Study: 36225172

Group type: COMPARATOR
Intervention: EBV‐miR‐BART5‐3p inhibitor
Number of subjects: 0

Group type: COMPARATOR
Intervention: EBV‐miR‐BART5‐3p inhibitors
Number of subjects: 0

Group type: COMPARATOR
Intervention: EBV‐miR‐BART5‐3p mimics
Number of subjects: 0

Group type: COMPARATOR
Intervention: EBV‐miR‐BART5‐3p
Number of subjects: 0
Study: 34213471

Group type: EXPERIMENTAL
Intervention: Alternate nostril breathing (ANB) exercise for 4 weeks
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 100
Study: 33801691

Group type: EXPERIMENTAL
Intervention: HIIT10 (48 × 10 s bouts at 100% of peak power with 15 s of recovery)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: HIIT60 (8 × 60 s bouts at 100% of peak power with 90 s of recovery)
Number of subjects: 16
Study: 36454387

Group type: EXPERIMENTAL
Intervention: Progressive Postural Control Exercise (PPCE)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Core Stability Exercise (CSE)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Both PPCE and CSE
Number of subjects: 34
Study: 33407488

Group type: EXPERIMENTAL
Intervention: Paracheck Pf® Test
Number of subjects: 702

Group type: EXPERIMENTAL
Intervention: ICT Malaria Pf™ Cassette Test
Number of subjects: 702

Group type: COMPARATOR
Intervention: Microscopy
Number of subjects: 702

Group type: COMPARATOR
Intervention: Polymerase Chain Reaction (PCR)
Number of subjects: 702
Study: 32878708

Group type: EXPERIMENTAL
Intervention: TAK-214 (15 μg GI.1 and 50 μg GII.4c VLPs, 0.5 mg Al(OH)3)
Number of subjects: 4712

Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 4712

Group type: EXPERIMENTAL
Intervention: TAK-214
Number of subjects: 4712
Study: 616670476

Group type: EXPERIMENTAL
Intervention: Intensity-modulated radiation therapy (IMRT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Volumetric-modulated arc therapy (VMAT)
Number of subjects: 60